- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-26-0107260

Mcare Formulation Private Limited
About Mcare Formulation Private Limited
Data last updated:
Mcare Formulation Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the watches and jewelry manufacturing segment of the consumer goods sector. It was incorporated on 19 April 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24100PN2021PTC200446. Its GSTIN is 27AAOCM5309D1ZG (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pratibha Amol Londhe and Amol Anil Londhe.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G No 1599(P) Fl No A 401 Abhang Vishwa Dehu Alandi Rd, Pune, Maharashtra, India – 411062.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.79 Cr, a decline of 46% compared to the previous year. For the same year it recorded a net profit of ₹4.87 Lakh (net margin 0.7%) and EBITDA of ₹7.76 Lakh (EBITDA margin 1.1%).
Mcare Formulation Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0107260).
Company details
Recognitions & Rankings of Mcare Formulation
Contact details
Mcare Formulation Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressG No 1599(P) Fl No A 401 Abhang Vishwa Dehu Alandi Rd, Pune, Maharashtra, India – 411062
- IndustryConsumer Goods, Watches & Jewelry Manufacturing
To see the full contact details of Mcare Formulation Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mcare Formulation is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Mcare Formulation Private Limited, buy the company report.
Financials of Mcare Formulation Private Limited
FY 2025 filings availableMcare Formulation Private Limited reported revenue of ₹6.79 Cr (down 46% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 46% in the latest year. EBITDA fell 57% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹7.76 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹4.87 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.1% | ||
| Net Profit Margin | 0.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Mcare Formulation Private Limited, buy the company report.
Board of directors of Mcare Formulation Private Limited
Mcare Formulation has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pratibha Amol Londhe | Director | 19 Apr 2021 | 5 Years 6 Months | Current |
| Amol Anil Londhe | Director | 19 Apr 2021 | 5 Years 6 Months | Current |
Auditor
Mcare Formulation Private Limited is audited by S S SHETYE & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S S SHETYE & ASSOCIATES | FY 2023 | 124823W |
Shareholding
The shareholding of Mcare Formulation Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Mcare Formulation Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mcare Formulation Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mcare Formulation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Mcare Formulation Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
GST
Mcare Formulation has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAOCM5309D1ZG | Maharashtra | Active | 05 May 2021 |
To see the full GST registrations and return filing status of Mcare Formulation Private Limited, buy the company report.
Recent activity
Mcare Formulation Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Amol Anil Londhe was appointed as Director on 19 Apr 2021.
Frequently asked questions
Mcare Formulation is an active private limited company based in Pune, Maharashtra, India. The company works in watches and jewelry manufacturing, within the consumer goods industry. It was incorporated on 19 April 2021 (5+ years old) and is registered under CIN U24100PN2021PTC200446.
Mcare Formulation has 2 current directors:
- Pratibha Amol Londhe - Director
- Amol Anil Londhe - Director
The latest financial statements of Mcare Formulation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Mcare Formulation is 27AAOCM5309D1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Mcare Formulation is U24100PN2021PTC200446. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mcare Formulation was incorporated on 19 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
Amol Anil Londhe was appointed as Director on 19 Apr 2021. Pratibha Amol Londhe was appointed as Director on 19 Apr 2021.
Yes, Mcare Formulation is registered as a small enterprise under Udyam registration (number: UDYAM-MH-26-0107260).
The registered office of Mcare Formulation is at G No 1599P Fl No A 401 Abhang Vishwa Dehu Alandi Rd, Pune, Maharashtra, India – 411062.
Mcare Formulation operates in the consumer goods industry, in the watches and jewelry manufacturing segment.